Taro Pharmaceutical Industries Ltd. – NYSE:TARO

Financial Health
0
1
2
3
4
5
6
7
8
9

Taro Pharmaceutical Industries Ltd. stock price monthly change

+1.06%
month

Taro Pharmaceutical Industries Ltd. stock price quarterly change

+1.46%
quarter

Taro Pharmaceutical Industries Ltd. stock price yearly change

+4.88%
year

Taro Pharmaceutical Industries Ltd. key metrics

Market Cap
1.61B
Enterprise value
N/A
P/E
14.36
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
1.64
Price/Book
0.55
PEG ratio
0.12
EPS
2.01
Revenue
593.77M
EBITDA
90.55M
Income
75.70M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
11.41%
Oper. margin
11.49%
Gross margin
49.52%
EBIT margin
11.49%
EBITDA margin
15.25%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Taro Pharmaceutical Industries Ltd. stock price history

Taro Pharmaceutical Industries Ltd. stock forecast

Taro Pharmaceutical Industries Ltd. financial statements

Taro Pharmaceutical Industries Ltd. (NYSE:TARO): Profit margin
Dec 2021 138.98M 26.31M 18.93%
Mar 2022 143.26M 27.40M 19.13%
Mar 2023 146.58M 6.91M 4.72%
Mar 2024 164.94M 15.07M 9.14%
Taro Pharmaceutical Industries Ltd. (NYSE:TARO): Debt to assets
Sep 2022 2107279000 400.99M 19.03%
Dec 2022 2117524000 397.58M 18.78%
Mar 2023 2135513000 404.65M 18.95%
Mar 2024 2162069000 369.06M 17.07%
Taro Pharmaceutical Industries Ltd. (NYSE:TARO): Cash Flow
Dec 2021 -191.93M -14.02M 0
Mar 2022 41.25M -108.60M 0
Mar 2023 56.65M 6.67M 0
Mar 2024 44.24M -52.32M 0

Taro Pharmaceutical Industries Ltd. alternative data

Taro Pharmaceutical Industries Ltd. (NYSE:TARO): Employee count
Aug 2023 1,554
Sep 2023 1,554
Oct 2023 1,554
Nov 2023 1,554
Dec 2023 1,554
Jan 2024 1,554
Feb 2024 1,554
Mar 2024 1,554
Apr 2024 1,554
May 2024 1,554
Jun 2024 1,554
Jul 2024 1,554

Taro Pharmaceutical Industries Ltd. other data

5.86% -4.58%
of TARO is owned by hedge funds
2.35M -1.83M
shares is hold by hedge funds

Taro Pharmaceutical Industries Ltd. (NYSE:TARO): Insider trades (number of shares)
Period Buy Sel
Sep 2010 2437919 0
Oct 2010 2333922 0
Nov 2010 5159765 5159765
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SUN PHARMACEUTICAL INDUSTRIES LTD 10 percent owner, other: Affili..
Ordinary Shares 5,159,765 N/A N/A
Sale
FRANKLIN RESOURCES INC 10 percent owner
Ordinary Shares 5,159,765 N/A N/A
Purchase
SUN PHARMACEUTICAL INDUSTRIES LTD 10 percent owner, other: Affili..
Ordinary Shares 2,333,922 N/A N/A
Purchase
SUN PHARMACEUTICAL INDUSTRIES LTD 10 percent owner, other: Affili..
Founders Shares 2,600 N/A N/A
Purchase
SUN PHARMACEUTICAL INDUSTRIES LTD 10 percent owner, other: Affili..
Ordinary Shares 2,405,937 N/A N/A
Purchase
SUN PHARMACEUTICAL INDUSTRIES LTD 10 percent owner, other: Affili..
Ordinary Shares 29,382 N/A N/A
Purchase
FRANKLIN RESOURCES INC 10 percent owner
Ordinary Shares 650,000 N/A N/A
Purchase
FRANKLIN RESOURCES INC 10 percent owner
Ordinary Shares 12,937 N/A N/A
Purchase
FRANKLIN RESOURCES INC 10 percent owner
Ordinary Shares 10,460 N/A N/A
Purchase
FRANKLIN RESOURCES INC 10 percent owner
Ordinary Shares 3,538 N/A N/A
Patent
Application
Filling date: 6 Mar 2020 Issue date: 10 Feb 2022
Application
Filling date: 29 Sep 2021 Issue date: 20 Jan 2022
Application
Filling date: 2 Aug 2021 Issue date: 23 Dec 2021
Grant
Filling date: 2 Feb 2021 Issue date: 16 Nov 2021
Application
Filling date: 2 Feb 2021 Issue date: 5 Aug 2021
Application
Filling date: 18 Jan 2019 Issue date: 25 Feb 2021
Application
Filling date: 9 Jan 2020 Issue date: 30 Jul 2020
Grant
Filling date: 3 May 2017 Issue date: 4 Feb 2020
Application
Filling date: 30 Aug 2017 Issue date: 31 Oct 2019
Insider Compensation
Mr. Ara Aprahamian (1968) Vice President of Sales & Marketing
$616,140
Tuesday, 12 November 2024
accesswire.com
Monday, 11 November 2024
accesswire.com
Sunday, 10 November 2024
globenewswire.com
accesswire.com
Friday, 8 November 2024
accesswire.com
Thursday, 7 November 2024
accesswire.com
Wednesday, 6 November 2024
accesswire.com
Tuesday, 5 November 2024
accesswire.com
Monday, 4 November 2024
globenewswire.com
accesswire.com
Sunday, 3 November 2024
accesswire.com
Friday, 1 November 2024
accesswire.com
Thursday, 31 October 2024
accesswire.com
Wednesday, 30 October 2024
accesswire.com
Tuesday, 29 October 2024
globenewswire.com
accesswire.com
Monday, 28 October 2024
accesswire.com
Sunday, 27 October 2024
accesswire.com
Wednesday, 23 October 2024
globenewswire.com
accesswire.com
Monday, 21 October 2024
accesswire.com
Sunday, 20 October 2024
accesswire.com
Wednesday, 16 October 2024
accesswire.com
Tuesday, 15 October 2024
accesswire.com
Monday, 14 October 2024
accesswire.com
Sunday, 13 October 2024
accesswire.com
Friday, 11 October 2024
globenewswire.com
accesswire.com
Thursday, 10 October 2024
accesswire.com
Wednesday, 9 October 2024
accesswire.com
  • When is Taro Pharmaceutical Industries Ltd.'s next earnings date?

    Unfortunately, Taro Pharmaceutical Industries Ltd.'s (TARO) next earnings date is currently unknown.

  • Does Taro Pharmaceutical Industries Ltd. pay dividends?

    No, Taro Pharmaceutical Industries Ltd. does not pay dividends.

  • How much money does Taro Pharmaceutical Industries Ltd. make?

    Taro Pharmaceutical Industries Ltd. has a market capitalization of 1.61B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.81% to 629.18M US dollars.

  • What is Taro Pharmaceutical Industries Ltd.'s stock symbol?

    Taro Pharmaceutical Industries Ltd. is traded on the NYSE under the ticker symbol "TARO".

  • What is Taro Pharmaceutical Industries Ltd.'s primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of Taro Pharmaceutical Industries Ltd.?

    Shares of Taro Pharmaceutical Industries Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Taro Pharmaceutical Industries Ltd.'s key executives?

    Taro Pharmaceutical Industries Ltd.'s management team includes the following people:

    • Mr. Ara Aprahamian Vice President of Sales & Marketing(age: 57, pay: $616,140)
  • How many employees does Taro Pharmaceutical Industries Ltd. have?

    As Jul 2024, Taro Pharmaceutical Industries Ltd. employs 1,554 workers.

  • When Taro Pharmaceutical Industries Ltd. went public?

    Taro Pharmaceutical Industries Ltd. is publicly traded company for more then 42 years since IPO on 14 Sep 1982.

  • What is Taro Pharmaceutical Industries Ltd.'s official website?

    The official website for Taro Pharmaceutical Industries Ltd. is taro.com.

  • How can i contact Taro Pharmaceutical Industries Ltd.?

    Taro Pharmaceutical Industries Ltd. can be reached via phone at +972 4 847 5700.

Taro Pharmaceutical Industries Ltd. company profile:

Taro Pharmaceutical Industries Ltd.

taro.com
Exchange:

NYSE

Full time employees:

1,554

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

14 Hakitor Street
Haifa, 2624761

CIK: 0000906338
ISIN: IL0010827181
CUSIP: M8737E108